Edition:
India

Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Global Market

1.46USD
2:29am IST
Change (% chg)

$0.01 (+0.69%)
Prev Close
$1.45
Open
$1.48
Day's High
$1.51
Day's Low
$1.46
Volume
35,616
Avg. Vol
60,975
52-wk High
$6.98
52-wk Low
$0.50

Chart for

About

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition,... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $43.07
Shares Outstanding(Mil.): 20.12
Dividend: --
Yield (%): --

Financials

BRIEF-Pulmatrix posts Q3 net loss of $0.22 per share

* Pulmatrix provides Q3 2017 highlights and Q3 2017 updated financials

10 Nov 2017

BRIEF-Vectura signs VR410 agreement with Pulmatrix

* PROGRESSING DEVELOPMENT OF BRANDED GENERIC TIOTROPIUM BROMIDE PROGRAMME (VR410) FOR US MARKET, ACCELERATED THROUGH LICENCE DEAL WITH PULMATRIX

06 Sep 2017

BRIEF-Pulmatrix says generated no revenue in Q2 of 2017

* Pulmatrix provides 2017 company year-to-date highlights and q2 2017 updated financials

04 Aug 2017

Earnings vs. Estimates